Author: Bonato, Matteo; Semenzato, Umberto; Tinè, Mariaenrica; Bazzan, Erica; Damin, Marco; Biondini, Davide; Casara, Alvise; Romagnoli, Micaela; Turato, Graziella; Cosio, Manuel G.; Saetta, Marina; Baraldo, Simonetta
Title: Risk Factors for Development and Severity of COVID-19 in COPD Patients Cord-id: rk35n00p Document date: 2021_8_9
ID: rk35n00p
Snippet: The impact that COVID-19 could have on patients with COPD is a real concern. In this study we evaluated, in a cohort of longitudinally followed COPD subjects, the incidence of COVID-19, seeking for possible risk factors and prognostic factors predicting the clinical outcome. In our cohort of 370 patients (followed for 5.3 ± 2.7 years), 22 developed COVID-19 (COPD/COVID-19+) between February/November 2020 (5.9%). Cardio-metabolic conditions (hypertension, dyslipidemia, obesity, diabetes) but not
Document: The impact that COVID-19 could have on patients with COPD is a real concern. In this study we evaluated, in a cohort of longitudinally followed COPD subjects, the incidence of COVID-19, seeking for possible risk factors and prognostic factors predicting the clinical outcome. In our cohort of 370 patients (followed for 5.3 ± 2.7 years), 22 developed COVID-19 (COPD/COVID-19+) between February/November 2020 (5.9%). Cardio-metabolic conditions (hypertension, dyslipidemia, obesity, diabetes) but not respiratory abnormalities (FEV(1), DLCO, emphysema and exacerbation history), were risk factors for development of COVID-19 in COPD patients. Out of the 22 COPD/COVID-19+ patients, 10 needed intensive care. Low DLCO and emphysema, but also metabolic comorbidities, were related to the need for intensive care.
Search related documents:
Co phrase search for related documents, hyperlinks ordered by date